Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 237,147,088 papers from all fields of science
Search
Sign In
Create Free Account
clusterin antisense oligonucleotide
Known as:
(3'-5')d(P-thio)([2'-O-(2-methoxyethyl)]m5rC-[2'-O-(2-methoxyethyl)]rA-[2'-O-(2- methoxyethyl)]rG-[2'-O-(2-methoxyethyl)]m5rC-A-G-C-A-G-A-G-T-C-T-T-C-A-[2'-O-(2- methoxyethyl)]m5rU-[2'-O-(2-methoxyethyl)]m5rC-[2'-O-(2-methoxyethyl)]rA-[2'-O-(2- methoxyethyl)]m5rU), Eicosasodium Salt
, CUSTIRSEN SODIUM
The eicosasodium salt of a mixed-backbone antisense oligodeoxynucleotide with chemosensitizing properties. Custirsen inhibits testosterone-repressed…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
Narrower (1)
OGX-011
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
CRPC: Neuer Behandlungsansatz kann Therapieresistenz verzögern
Martina-Jasmin Utzt
Uro-News
2013
Corpus ID: 45532975
— Obwohl viele Patienten mit kastrationsresistentem Prostatakarzinom (CRPC) zunächst gut auf eine antiandrogene Behandlung oder…
Expand
2013
2013
Kombinationstherapie wirksam gegen BPS-Komplikationen
R. Fath
Uro-News
2013
Corpus ID: 44735392
— Obwohl viele Patienten mit kastrationsresistentem Prostatakarzinom (CRPC) zunächst gut auf eine antiandrogene Behandlung oder…
Expand
1999
1999
An intratumoral controlled release formulation of clusterin antisense oligonucleotide and paclitaxel or docetaxel for treatment of prostate tumors
C. Springate
1999
Corpus ID: 75223715